Abbreviated Contents |
|
v | |
Contributors |
|
xv | |
Preface |
|
xix | |
SECTION 1 IMPORTANT SIGNS AND SYMPTOMS |
|
|
|
1 | (5) |
|
|
6 | (5) |
|
|
11 | (4) |
|
|
15 | (7) |
|
|
22 | (10) |
|
|
32 | (4) |
|
|
36 | (1) |
|
Pain or Swelling of Joints |
|
|
37 | (5) |
|
|
42 | (3) |
|
|
45 | (2) |
|
Visual Loss and Disorders of Ocular Motility |
|
|
47 | (5) |
|
Paralysis and Movement Disorders |
|
|
52 | (5) |
|
Alterations in Consciousness (Confusion, Stupor, and Coma) |
|
|
57 | (4) |
|
|
61 | (2) |
|
|
63 | (6) |
|
|
69 | (2) |
|
|
71 | (5) |
|
|
76 | (2) |
|
Weight Loss and Weight Gain |
|
|
78 | (3) |
|
Diarrhea, Constipation, and Malabsorption |
|
|
81 | (8) |
|
Gastrointestinal Bleeding |
|
|
89 | (5) |
|
Jaundice and Evaluation of Liver Function |
|
|
94 | (6) |
|
|
100 | (5) |
|
Overt Manifestations of Renal Disease |
|
|
105 | (6) |
|
Electrolytes/Acid-Base Balance |
|
|
111 | (16) |
|
Lymphadenopathy and Splenomegaly |
|
|
127 | (4) |
SECTION 2 MEDICAL EMERGENCIES |
|
|
Cardiovascular Collapse and Sudden Death |
|
|
131 | (5) |
|
|
136 | (6) |
|
|
142 | (3) |
|
Emergency Room Evaluation of Stroke |
|
|
145 | (4) |
|
Increased Intracranial Pressure and Head Trauma |
|
|
149 | (2) |
|
|
151 | (3) |
|
Poisoning and Its Management |
|
|
154 | (19) |
|
Diabetic Ketoacidosis and Hyperosmotic Coma |
|
|
173 | (3) |
|
|
176 | (4) |
|
|
180 | (4) |
|
|
184 | (6) |
|
Drowning and Near-Drowning |
|
|
190 | (3) |
|
Anaphylaxis and Transfusion Reaction |
|
|
193 | (3) |
|
Bites, Envenomations, Stings, and Ectoparasite Infestations |
|
|
196 | (14) |
|
|
210 | (3) |
SECTION 3 DERMATOLOGY |
|
|
General Examination of the Skin |
|
|
213 | (6) |
|
|
219 | (8) |
SECTION 4 NUTRITION |
|
|
Nutritional Requirements and Assessment |
|
|
227 | (5) |
|
Anorexia Nervosa and Bulimia |
|
|
232 | (4) |
|
|
236 | (4) |
|
|
240 | (7) |
SECTION 5 HEMATOLOGY AND ONCOLOGY |
|
|
Examination of Blood Smears and Bone Marrow |
|
|
247 | (3) |
|
|
250 | (8) |
|
Leukocytosis and Leukopenia |
|
|
258 | (4) |
|
Bleeding and Thrombotic Disorders |
|
|
262 | (6) |
|
Transfusion and Pheresis Therapy |
|
|
268 | (3) |
|
|
271 | (4) |
|
Myeloid Leukemias, Myelodysplasia, and Myeloproliferative Syndromes |
|
|
275 | (9) |
|
|
284 | (14) |
|
|
298 | (3) |
|
|
301 | (2) |
|
|
303 | (4) |
|
|
307 | (4) |
|
Tumors of the Gastrointestinal Tract |
|
|
311 | (12) |
|
Genitourinary Tract Cancer |
|
|
323 | (4) |
|
|
327 | (4) |
|
Prostate Hyperplasia and Carcinoma |
|
|
331 | (4) |
|
Cancer of Unknown Primary Site |
|
|
335 | (4) |
|
Sarcomas of Bone and Soft Tissues |
|
|
339 | (3) |
|
|
342 | (3) |
|
Neurologic Manifestations of Systemic Neoplasia |
|
|
345 | (6) |
SECTION 6 INFECTIOUS DISEASES |
|
|
|
351 | (11) |
|
|
362 | (10) |
|
Immunization and Advice to Travelers |
|
|
372 | (9) |
|
|
381 | (6) |
|
|
387 | (9) |
|
|
396 | (3) |
|
|
399 | (6) |
|
Sexually Transmitted Diseases |
|
|
405 | (16) |
|
Infections of Skin, Soft Tissues, Joints, and Bones |
|
|
421 | (8) |
|
Infections in the Immunocompromised Host |
|
|
429 | (6) |
|
|
435 | (12) |
|
Hospital-Acquired Infections |
|
|
447 | (3) |
|
|
450 | (4) |
|
Staphylococcal Infections |
|
|
454 | (10) |
|
Streptococcal and Enterococcal Infections and Diphtheria |
|
|
464 | (9) |
|
Meningococcal and Listerial Infections |
|
|
473 | (4) |
|
Infections Caused by Haemophilus, Bordetella, Moraxella, and HACEK Group Organisms |
|
|
477 | (4) |
|
Diseases Caused by Gram-Negative Enteric Bacteria, Pseudomonas, and Legionella |
|
|
481 | (9) |
|
Diseases Caused by Other Gram-Negative Bacteria |
|
|
490 | (5) |
|
|
495 | (8) |
|
Nocardiosis and Actinomycosis |
|
|
503 | (4) |
|
Tuberculosis and Other Mycobacterial Infections |
|
|
507 | (13) |
|
Lyme Disease and Other Spirochetal Infections |
|
|
520 | (7) |
|
|
527 | (9) |
|
|
536 | (2) |
|
|
538 | (3) |
|
|
541 | (8) |
|
Cytomegalovirus and Epstein-Barr Virus Infections |
|
|
549 | (5) |
|
Influenza and Other Viral Respiratory Diseases |
|
|
554 | (7) |
|
Rubeola, Rubella, Mumps, and Parvovirus Infections |
|
|
561 | (7) |
|
|
568 | (3) |
|
Insect-and Animal-Borne Viral Infections |
|
|
571 | (12) |
|
|
583 | (10) |
|
Pneumocystis carinii Infection |
|
|
593 | (2) |
|
|
595 | (17) |
|
|
612 | (9) |
SECTION 7 CARDIOVASCULAR DISEASES |
|
|
Physical Examination of the Heart |
|
|
621 | (6) |
|
Electrocardiography and Echocardiography |
|
|
627 | (8) |
|
Preoperative Evaluation of Cardiovascular Disease |
|
|
635 | (3) |
|
|
638 | (11) |
|
Congestive Heart Failure and Cor Pulmonale |
|
|
649 | (6) |
|
Congenital Heart Disease in the Adult |
|
|
655 | (3) |
|
|
658 | (7) |
|
Cardiomyopathies and Myocarditis |
|
|
665 | (5) |
|
|
670 | (4) |
|
Acute Myocardial Infarction |
|
|
674 | (14) |
|
Chronic Coronary Artery Disease |
|
|
688 | (8) |
|
|
696 | (10) |
|
|
706 | (4) |
|
Peripheral Vascular Disease |
|
|
710 | (5) |
SECTION 8 RESPIRATORY DISEASES |
|
|
Respiratory Function and Diagnosis |
|
|
715 | (7) |
|
Asthma and Hypersensitivity Pneumonitis |
|
|
722 | (5) |
|
Environmental Lung Diseases |
|
|
727 | (3) |
|
Chronic Bronchitis, Emphysema, and Acute Respiratory Failure |
|
|
730 | (5) |
|
Upper and Lower Respiratory Tract Infections |
|
|
735 | (10) |
|
Pulmonary Thromboembolism and Primary Pulmonary Hypertension |
|
|
745 | (5) |
|
Interstitial Lung Disease (ILD) |
|
|
750 | (3) |
|
Diseases of the Pleura, Mediastinum, and Diaphragm |
|
|
753 | (6) |
|
Disorders of Ventilation, including Sleep Apnea |
|
|
759 | (5) |
|
Pulmonary Insufficiency and Acute Respiratory Distress Syndrome (ARDS) |
|
|
764 | (3) |
SECTION 9 RENAL DISEASES |
|
|
Approach to Patient with Renal Disease |
|
|
767 | (5) |
|
Acute Renal Failure (ARF) |
|
|
772 | (5) |
|
Chronic Renal Failure (CRF) and Uremia |
|
|
777 | (4) |
|
Dialysis and Transplantation |
|
|
781 | (5) |
|
|
786 | (9) |
|
|
795 | (5) |
|
|
800 | (3) |
|
|
803 | (4) |
|
|
807 | (3) |
|
Urinary Tract Obstruction |
|
|
810 | (3) |
SECTION 10 GASTROINTESTINAL DISEASES |
|
|
|
813 | (5) |
|
Peptic Ulcer and Related Disorders |
|
|
818 | (8) |
|
Inflammatory Bowel Diseases |
|
|
826 | (5) |
|
Colonic and Anorectal Diseases |
|
|
831 | (4) |
|
Cholelithiasis, Cholecystitis, and Cholangitis |
|
|
835 | (5) |
|
|
840 | (5) |
|
|
845 | (7) |
|
|
852 | (4) |
|
Cirrhosis and Alcoholic Liver Disease |
|
|
856 | (5) |
|
|
861 | (6) |
SECTION 11 ALLERGY, CLINICAL IMMUNOLOGY, AND RHEUMATOLOGY |
|
|
Diseases of Immediate-Type Hypersensitivity |
|
|
867 | (4) |
|
Primary Immunodeficiency Diseases |
|
|
871 | (5) |
|
SLE, RA, and Other Connective Tissue Diseases |
|
|
876 | (10) |
|
|
886 | (5) |
|
|
891 | (2) |
|
|
893 | (3) |
|
Degenerative Joint Disease |
|
|
896 | (3) |
|
Gout, Pseudogout, and Related Diseases |
|
|
899 | (4) |
|
|
903 | (2) |
|
Reactive Arthritis and Reiter's Syndrome |
|
|
905 | (2) |
|
|
907 | (4) |
|
|
911 | (2) |
SECTION 12 ENDOCRINOLOGY AND METABOLISM |
|
|
Disorders of the Anterior Pituitary and Hypothalamus |
|
|
913 | (10) |
|
Disorders of the Posterior Pituitary |
|
|
923 | (5) |
|
|
928 | (8) |
|
Diseases of the Adrenal Cortex |
|
|
936 | (7) |
|
|
943 | (4) |
|
Disorders of the Testes and Prostate |
|
|
947 | (7) |
|
Disorders of the Ovary and Female Genital Tract |
|
|
954 | (5) |
|
Hyper-and Hypocalcemic Disorders |
|
|
959 | (10) |
|
|
969 | (3) |
|
Disorders of Lipid Metabolism |
|
|
972 | (8) |
|
Inherited Metabolic Diseases |
|
|
980 | (5) |
SECTION 13 NEUROLOGY |
|
|
The Neurologic Examination |
|
|
985 | (7) |
|
Diagnostic Methods in Neurology |
|
|
992 | (6) |
|
|
998 | (8) |
|
|
1006 | (8) |
|
Neoplastic Diseases of the Central Nervous System |
|
|
1014 | (3) |
|
Bacterial Infections of the Central Nervous System |
|
|
1017 | (6) |
|
Aseptic Meningitis, Viral Encephalitis, and Prion Diseases |
|
|
1023 | (9) |
|
|
1032 | (6) |
|
Alzhemier's Disease and Other Dementias |
|
|
1038 | (6) |
|
|
1044 | (3) |
|
|
1047 | (3) |
|
Motor Neuron Disease, including ALS |
|
|
1050 | (3) |
|
|
1053 | (4) |
|
|
1057 | (7) |
|
|
1064 | (3) |
|
Disorders of the Autonomic Nervous System |
|
|
1067 | (6) |
|
Disorders of Sleep and Circadian Rhythms |
|
|
1073 | (5) |
|
|
1078 | (6) |
|
Peripheral Neuropathies including Guillain-Barre Syndrome |
|
|
1084 | (5) |
|
Myopathies and Muscular Dystrophies |
|
|
1089 | (7) |
|
|
1096 | (3) |
SECTION 14 PSYCHIATRIC DISORDERS AND PSYCHOACTIVE SUBSTANCE USE |
|
|
Approach to the Patient with Psychiatric Symptoms |
|
|
1099 | (8) |
|
|
1107 | (12) |
|
|
1119 | (3) |
|
|
1122 | (3) |
SECTION 15 ADVERSE DRUG REACTIONS |
|
|
|
1125 | (14) |
SECTION 16 LABORATORY VALUES |
|
|
|
1139 | (8) |
Index |
|
1147 | |